Twist Bioscience Stock Forecast, Price & News

Twist Bioscience's stock was trading at $28.20 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, TWST stock has increased by 181.6% and is now trading at $79.41.
View which stocks have been most impacted by COVID-19.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Twist Bioscience in the last year. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Twist Bioscience.

Twist Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, December 9th 2020.
View our earnings forecast for Twist Bioscience.

Twist Bioscience Co. (NASDAQ:TWST) posted its quarterly earnings results on Thursday, August, 6th. The company reported ($0.67) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.72) by $0.05. The business earned $21.20 million during the quarter, compared to the consensus estimate of $13.67 million. Twist Bioscience had a negative net margin of 199.98% and a negative return on equity of 57.24%. The firm's quarterly revenue was up 55.9% compared to the same quarter last year.
View Twist Bioscience's earnings history.

3 brokers have issued 12-month price objectives for Twist Bioscience's shares. Their forecasts range from $42.00 to $42.00. On average, they anticipate Twist Bioscience's stock price to reach $42.00 in the next year. This suggests that the stock has a possible downside of 47.1%.
View analysts' price targets for Twist Bioscience.

Some companies that are related to Twist Bioscience include argenx (ARGX), Qiagen (QGEN), BIO-TECHNE (TECH), Neurocrine Biosciences (NBIX), Repligen (RGEN), Adaptive Biotechnologies (ADPT), Crispr Therapeutics (CRSP), Acceleron Pharma (XLRN), Momenta Pharmaceuticals (MNTA), Iovance Biotherapeutics (IOVA), Novavax (NVAX), Allogene Therapeutics (ALLO), Denali Therapeutics (DNLI), China Biologic Products (CBPO) and Kodiak Sciences (KOD).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Twist Bioscience investors own include CrowdStrike (CRWD), Pfizer (PFE), Docusign (DOCU), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Gilead Sciences (GILD), JD.com (JD), Tesla (TSLA) and Twilio (TWLO).

(TWST) raised $75 million in an initial public offering (IPO) on Wednesday, October 31st 2018. The company issued 5,000,000 shares at $14.00-$16.00 per share. J.P. Morgan and Cowen served as the underwriters for the IPO and Allen & Company and Baird were co-managers.

Twist Bioscience trades on the NASDAQ under the ticker symbol "TWST."

Twist Bioscience's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Emerald Advisers LLC (0.88%), Emerald Mutual Fund Advisers Trust (0.85%), State of Michigan Retirement System (0.12%), State of New Jersey Common Pension Fund D (0.07%), Conestoga Capital Advisors LLC (0.03%) and Ballentine Partners LLC (0.01%). Company insiders that own Twist Bioscience stock include Bill Peck, Emily M Leproust, James M Thorburn, Keith Crandell, Mark Daniels, Patrick John Finn, Patrick Weiss, Paula Green and William Banyai.
View institutional ownership trends for Twist Bioscience.

TWST stock was sold by a variety of institutional investors in the last quarter, including Emerald Advisers LLC, Emerald Mutual Fund Advisers Trust, Conestoga Capital Advisors LLC, and State of New Jersey Common Pension Fund D. Company insiders that have sold Twist Bioscience company stock in the last year include Emily M Leproust, James M Thorburn, Mark Daniels, Patrick John Finn, Patrick Weiss, Paula Green, and William Banyai.
View insider buying and selling activity for Twist Bioscience.

TWST stock was purchased by a variety of institutional investors in the last quarter, including State of Michigan Retirement System, Ballentine Partners LLC, Arthur M. Cohen & Associates LLC, Pacer Advisors Inc., Harel Insurance Investments & Financial Services Ltd., and Nisa Investment Advisors LLC.
View insider buying and selling activity for Twist Bioscience.

Shares of TWST can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of TWST stock can currently be purchased for approximately $79.41.

Twist Bioscience has a market capitalization of $3.55 billion and generates $54.38 million in revenue each year. The company earns $-107,670,000.00 in net income (profit) each year or ($3.92) on an earnings per share basis. Twist Bioscience employs 414 workers across the globe.

The official website for Twist Bioscience is www.twistbioscience.com.

Twist Bioscience's mailing address is 681 GATEWAY BLVD., SOUTH SAN FRANCISCO CA, 94080. The company can be reached via phone at 800-719-0671 or via email at [email protected]